A virus-like particle vaccine candidate for Crimean-Congo haemorrhagic fever has shown experimental rapid onset and durable ...

The Wistar Institute has appointed Vincent Wu, PhD, as a Caspar Wistar Fellow in its Vaccine & Immunotherapy Center, bringing ...

Scientists create a vaccine that shields against Crimean-Congo hemorrhagic fever within days and protects for over a year ...

New approaches hurdle biological barriers to attack recalcitrant targets to tackle difficult-to-treat and recurrent cancers.

Scientists create a vaccine that shields against Crimean-Congo hemorrhagic fever within days and protects for over a year.

Global cocoa prices have surged to historic highs this year, rattling supply chains and putting pressure on manufacturers ...

People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus ...

Antibiotics are no longer able to treat infections as effectively as they once did because many pathogens have developed ...